TP Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$720.7M
Lead Investor(s):Foresite Capital, VenBio Partners

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • TP Therapeutics's estimated annual revenue is currently $31.8M per year.(?)
  • TP Therapeutics received $80.0M in venture funding in October 2018.
  • TP Therapeutics's estimated revenue per employee is $155,000
  • TP Therapeutics's total funding is $720.7M.

Employee Data

  • TP Therapeutics has 205 Employees.(?)
  • TP Therapeutics grew their employee count by 101% last year.
  • TP Therapeutics currently has 23 job openings.

TP Therapeutics, Inc. (TP) is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. Our lead therapeutic project, TPX-0005, is in clinical development (TRIDENT-1). TP- Turning Point Medicines for Life!